403
Sorry!!
Error! We're sorry, but the page you were
looking for doesn't exist.
Pathology Laboratories Market Size To Reach USD 720.60 Billion By 2032, Driven By AI Integration And Rising Chronic Disease Burden – SNS Insider
| Report Attributes | Details |
| Market Size in 2023 | US$ 355.56 billion |
| Market Size by 2032 | US$ 720.60 billion |
| CAGR | CAGR of 8.13% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Regional Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
Segmentation Analysis
By Type
The hospital-based segment held the largest share of the market in 2023, accounting for 53.65% of the global revenue. The clinical labs are part of the integrated clinical ecosystem of hospitals which facilitates a streamlined workflow for specimen workflow/module collection, processing, diagnosis, and reporting. Hospital labs are particularly important in emergency departments and inpatient settings, where obtaining test results quickly can impact clinical decisions and outcomes. And hospital-based labs are also earlier adopters of automation and digital pathology tools given greater resources and access to skilled manpower. Specialist diagnostics is provided by the centralized setup. Keying and the typical testing volume must handle for routine and complicated testing protocols across specialties like oncology hematology and infectious disease diagnostics.
By Testing Services
In 2023, the largest segment of the market was General Physiological & Clinical Tests, which accounted for 38.15% of total revenue. This segment includes routine blood tests, urine analysis, lipid profiles, liver function tests, and blood glucose monitoring tests used frequently in annual health check-ups and chronic disease management. Segmental growth can be ascribed to the rapidly increasing prevalence of diabetes, hypertension, and metabolic disorders worldwide. These tests are used widely, partly because they are affordable and accessible at outpatient sites. Governments and insurers also actively encourage routine health screenings, as they are cheaper in the long run and, in the case of early detection, can help offset the costs of treatment. With the rising awareness of preventive healthcare, the demand for such routine tests is also one of the major aspects driving the market, especially in emerging economies.
By End-Use
In 2023, the largest end-use segment was Physician Referrals, which contributed 53.41% of the global market. Patients are prescribed or referred to diagnostic tests by primary care providers and specialists. This referral pathway is the key driver of pathology lab utilization. Accurate and prompt diagnostic data is essential for physicians to make informed treatment decisions, particularly concerning chronic diseases such as cancer and cardiovascular diseases. Growth in the volume of tests processed through referrals has also come from increasing collaboration between general practitioners and diagnostic centers. Additionally, private pathology labs often maintain close relationships with physicians and clinics, providing efficient sample collection services and report integration into electronic health records (EHRs), enhancing operational synergy and patient care.
Need Any Customization Research on Pathology Laboratories Market, Enquire Now@
Pathology Laboratories Market Segmentation
By Type
- Hospital-based Standalone Labs Diagnostic Chains
By Testing Services
- General Physiological & Clinical Tests Imaging & Radiology Tests Esoteric Tests COVID-19 Tests
By End-Use
- Physician Referrals Walk-ins Corporate
Regional Analysis
North America led the pathology laboratories market in 2023, holding 38.25% of the global share. The region's dominance can be attributed to high healthcare expenditure, regulatory requirements, and the early adoption of digital pathology and AI-enabled diagnostics. The Precision Medicine Initiative and the Cancer Moonshot Program have both amplified funding for diagnostic innovation in the U.S. Moreover, the rising geriatric population and expanding Medicare coverage of laboratory tests also contribute to the market growth. Similarly, the presence of leading diagnostic companies including LabCorp, Quest Diagnostics, and Mayo Clinic Laboratories adds to the competitive landscape of the U.S. market.
The region is anticipated to record the highest compound annual growth rate (CAGR) over the forecast period. India, China, and Japan are significantly investing in expanding healthcare infrastructure, including diagnostic laboratory networks, as well as subsidizing health screening programs. Key growth drivers include rising disposable income, urbanization, and increasing awareness in preventive healthcare. In the coming years, government initiatives such as India's Ayushman Bharat and China's Healthy China 2030 are expected to drive access to diagnostics in rural and semi-urban areas, opening up enormous opportunities for pathology laboratories.
Recent Developments
- LabCorp launched its AI-powered pathology platform in Q4 2023 to enhance efficiency in cancer diagnostics and reduce turnaround times for histopathological evaluations. In March 2024, Quest Diagnostics partnered with Google Cloud to digitize its nationwide pathology network, aiming to improve diagnostic accuracy and enable remote consultations through AI tools.
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
6. Competitive Landscape
7. Pathology Laboratories Market by Type
8. Pathology Laboratories Market by Testing Services
9. Pathology Laboratories Market by End-Use
10. Regional Analysis
11. Company Profiles
12. Use Cases and Best Practices
13. Conclusion
RELATED REPORTS
Clinical Laboratory Services Market Forecast 2024–2032
AI in Diagnostics Market Analysis
Digital Pathology Market Outlook
Laboratory Information Management Systems Market Report
Molecular Diagnostics Market Trends
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Most popular stories
More Story
Comments
No comment